The Global ventilator market is expected to reach USD 14,613.84 million by 2031 from USD 7,645.11 million in 2023, growing at a CAGR of 8.6% during the forecast period of 2024 to 2031.
Market Segmentation
Global Ventilator Market, By Product Type (Intensive Care Ventilators, Portable Ventilators, and Neonatal Ventilators), Modality (Invasive Ventilation and Non-Invasive Ventilation), Type(Adult Ventilators, Neonatal Ventilators, and Pediatric Ventilators), Mode(Combined-Mode Ventilation, Volume-Mode Ventilation, Pressure-Mode Ventilator, and Other), End User (Hospitals, Specialty Clinics, Homecare Settings, Long Term Care Centers, and Rehabilitation Centers), Country (U.S., Canada, Mexico, Germany, U.K., France, Spain, Italy, Switzerland, Netherlands, Belgium, Russia, Turkey, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia Pacific, Brazil, Rest of South America, South Africa, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2031.
Overview of Global Ventilator Market Dynamics
- Drivers
- Increasing prevalence of chronic respiratory diseases
- Increasing geriatric population prone to respiratory disorders
- Restraint
- Side effects associated with the usage of ventilators
- Opportunity
- Increasing healthcare expenditure
Market Players
Some of the major market players operating in the Global ventilator market are:
- Koninklijke Philips N.V.
- GE Healthcare
- VYAIRE
- Dragerwerk AG & Co. KGaA
- Getinge AB
- Medtronic
- Air Liquide
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Smiths Group plc
- ResMed
- Hamilton Medical
- Fisher & Paykel Healthcare Limited.
- Penlon Limited
- Leistung Equipamentos LTDA
- Zoll Medical Corporation
TABLE OF CONTENTS
1 INTRODUCTION 21
- 1.1 OBJECTIVES OF THE STUDY 21
- 1.2 MARKET DEFINITION 21
- 1.3 OVERVIEW OF THE GLOBAL VENTILATOR MARKET 21
- 1.4 LIMITATIONS 23
- 1.5 MARKETS COVERED 23
2 MARKET SEGMENTATION 25
- 2.1 MARKETS COVERED 25
- 2.2 GEOGRAPHICAL SCOPE 26
- 2.3 YEARS CONSIDERED FOR THE STUDY 27
- 2.4 CURRENCY AND PRICING 27
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL 28
- 2.6 MULTIVARIATE MODELLING 31
- 2.7 PRODUCT TYPE VENTILATOR LIFELINE CURVE 32
- 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 33
- 2.9 DBMR MARKET POSITION GRID 34
- 2.10 SECONDARY SOURCES 35
- 2.11 ASSUMPTIONS 35
3 EXECUTIVE SUMMARY 36
4 PREMIUM INSIGHTS 39
5 MARKET OVERVIEW 42
- 5.1 DRIVERS 44
- 5.1.1 INCREASING PREVALENCE OF CHRONIC RESPIRATORY DISEASES 44
- 5.1.2 INCREASING GERIATRIC POPULATION PRONE TO RESPIRATORY DISORDERS 45
- 5.1.3 INCREASING NUMBER OF ICU BED 45
- 5.1.4 TECHNOLOGICAL ADVANCEMENT IN THE VENTILATORS 46
- 5.2 RESTRAINTS 47
- 5.2.1 SIDE EFFECTS ASSOCIATED WITH THE USAGE OF VENTILATORS 47
- 5.2.2 HIGH COST OF VENTILATORS 48
- 5.3 OPPORTUNITIES 49
- 5.3.1 INCREASING HEALTHCARE EXPENDITURE 49
- 5.3.2 RISING NUMBER OF PREMATURE BIRTHS 51
- 5.3.3 INCREASING USAGE OF ICU EQUIPMENT 52
- 5.4 CHALLENGE 53
- 5.4.1 STRINGENT LEGAL FRAMEWORK 53
- 5.4.2 RISK ASSOCIATED WITH THE MECHANICAL VENTILATION 54
6 GLOBAL VENTILATOR MARKET, BY PRODUCT TYPE 56
- 6.1 OVERVIEW 57
- 6.2 INTENSIVE CARE VENTILATORS 60
- 6.2.1 HIGH-END ICU VENTILATORS 61
- 6.2.2 BASIC ICU VENTILATORS 61
- 6.2.3 MID-END ICU VENTILATORS 61
- 6.3 PORTABLE VENTILATORS 61
- 6.4 NEONATAL VENTILATORS 61
7 GLOBAL VENTILATOR MARKET, BY MODALITY 62
- 7.1 OVERVIEW 63
- 7.2 INVASIVE VENTILATION 66
- 7.3 NON-INVASIVE VENTILATION 66
- 7.3.1 VOLUME-CYCLED VENTILATORS 67
- 7.3.2 PRESSURE-CYCLED VENTILATORS 67
- 7.3.3 CONTINUOUS POSITIVE AIRWAY PRESSURE VENTILATORS 67
- 7.3.4 BI-LEVEL POSITIVE AIRWAY PRESSURE VENTILATORS 67
- 7.3.5 FLOW-CYCLED VENTILATORS 67
- 7.3.6 TIME-CYCLED VENTILATORS 67
8 GLOBAL VENTILATOR MARKET, BY VENTILATOR TYPE 68
- 8.1 OVERVIEW 69
- 8.2 ADULT VENTILATORS 72
- 8.3 NEONATAL VENTILATORS 72
- 8.4 PEDIATRIC VENTILATORS 73
9 GLOBAL VENTILATOR MARKET, BY MODE 74
- 9.1 OVERVIEW 75
- 9.2 COMBINED-MODE VENTILATION 78
- 9.3 VOLUME-MODE VENTILATION 78
- 9.4 PRESSURE-MODE VENTILATOR 79
- 9.5 OTHER 79
10 GLOBAL VENTILATOR MARKET, BY END USER 80
- 10.1 OVERVIEW 81
- 10.2 HOSPITALS 84
- 10.3 SPECIALTY CLINICS 84
- 10.4 HOMECARE SETTINGS 85
- 10.5 LONG TERM CARE CENTRES 85
- 10.6 REHABILITATION CENTRES 86
- 10.7 OTHERS 86
11 GLOBAL VENTILATOR MARKET, BY REGION 87
- 11.1 OVERVIEW 88
- 11.2 NORTH AMERICA 91
- 11.2.1 U.S. 94
- 11.2.2 CANADA 97
- 11.2.3 MEXICO 100
- 11.3 EUROPE 103
- 11.3.1 U.K. 108
- 11.3.2 FRANCE 111
- 11.3.3 SPAIN 114
- 11.3.4 ITALY 117
- 11.3.5 SWITZERLAND 120
- 11.3.6 NETHERLANDS 123
- 11.3.7 BELGIUM 126
- 11.3.8 RUSSIA 129
- 11.3.9 TURKEY 132
- 11.3.10 REST OF EUROPE 135
- 11.4 ASIA-PACIFIC 136
- 11.4.1 JAPAN 139
- 11.4.2 CHINA 142
- 11.4.3 INDIA 145
- 11.4.4 SOUTH KOREA 148
- 11.4.5 AUSTRALIA 151
- 11.4.6 SINGAPORE 154
- 11.4.7 THAILAND 157
- 11.4.8 MALAYSIA 160
- 11.4.9 INDONESIA 163
- 11.4.10 PHILIPPINES 166
- 11.4.11 REST OF ASIA-PACIFIC 169
- 11.5 SOUTH AMERICA 170
- 11.5.1 BRAZIL 173
- 11.5.2 REST OF SOUTH AMERICA 176
- 11.6 MIDDLE EAST AND AFRICA 177
- 11.6.1 SOUTH AFRICA 180
- 11.6.2 REST OF MIDDLE EAST AND AFRICA 183
12 GLOBAL VENTILATOR MARKET: COMPANY LANDSCAPE 184
- 12.1 COMPANY SHARE ANALYSIS: GLOBAL 184
13 NORTH AMERICA VENTILATOR MARKET: COMPANY LANDSCAPE 185
- 13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 185
14 EUROPE VENTILATOR MARKET: COMPANY LANDSCAPE 186
- 14.1 COMPANY SHARE ANALYSIS: EUROPE 186
15 ASIA-PACIFIC VENTILATOR MARKET: COMPANY LANDSCAPE 187
- 15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 187
16 SWOT ANALYSIS 188
17 COMPANY PROFILES 189
- 17.1 KONINKLIJKE PHILIPS N.V. 189
- 17.1.1 COMPANY SNAPSHOT 189
- 17.1.2 REVENUE ANALYSIS 189
- 17.1.3 COMPANY SHARE ANALYSIS 190
- 17.1.4 PRODUCT PORTFOLIO 190
- 17.1.5 RECENT DEVELOPMENT 192
- 17.2 GE HEALTHCARE 193
- 17.2.1 COMPANY SNAPSHOT 193
- 17.2.2 REVENUE ANALYSIS 193
- 17.2.3 COMPANY SHARE ANALYSIS 194
- 17.2.4 PRODUCT PORTFOLIO 194
- 17.2.5 RECENT DEVELOPMENT 194
- 17.3 VYAIRE 195
- 17.3.1 COMPANY SNAPSHOT 195
- 17.3.2 COMPANY SHARE ANALYSIS 195
- 17.3.3 PRODUCT PORTFOLIO 196
- 17.3.4 RECENT DEVELOPMENTS 199
- 17.4 DRAGERWERK AG & CO. KGAA 200
- 17.4.1 COMPANY SNAPSHOT 200
- 17.4.2 REVENUE ANALYSIS 200
- 17.4.3 COMPANY SHARE ANALYSIS 201
- 17.4.4 PRODUCT PORTFOLIO 201
- 17.4.5 RECENT DEVELOPMENTS 204
- 17.5 GETINGE AB 205
- 17.5.1 COMPANY SNAPSHOT 205
- 17.5.2 REVENUE ANALYSIS 205
- 17.5.3 COMPANY SHARE ANALYSIS 206
- 17.5.4 PRODUCT PORTFOLIO 206
- 17.5.5 RECENT DEVELOPMENT 207
- 17.6 AIR LIQUIDE 208
- 17.6.1 COMPANY SNAPSHOT 208
- 17.6.2 REVENUE ANALYSIS 208
- 17.6.3 PRODUCT PORTFOLIO 209
- 17.6.4 RECENT DEVELOPMENT 210
- 17.7 FISHER & PAYKEL HEALTHCARE LIMITED 211
- 17.7.1 COMPANY SNAPSHOT 211
- 17.7.2 REVENUE ANALYSIS 211
- 17.7.3 PRODUCT PORTFOLIO 212
- 17.7.4 RECENT DEVELOPMENTS 212
- 17.8 HAMILTON MEDICAL 213
- 17.8.1 COMPANY SNAPSHOT 213
- 17.8.2 PRODUCT PORTFOLIO 213
- 17.8.3 RECENT DEVELOPMENTS 215
- 17.9 LEISTUNG EQUIPAMENTOS LTDA. 216
- 17.9.1 COMPANY SNAPSHOT 216
- 17.9.2 PRODUCT PORTFOLIO 216
- 17.9.3 RECENT DEVELOPMENT 216
- 17.10 MEDTRONIC 217
- 17.10.1 COMPANY SNAPSHOT 217
- 17.10.2 REVENUE ANALYSIS 217
- 17.10.3 PRODUCT PORTFOLIO 218
- 17.10.4 RECENT DEVELOPMENTS 219
- 17.11 PENLON LIMITED 220
- 17.11.1 COMPANY SNAPSHOT 220
- 17.11.2 PRODUCT PORTFOLIO 220
- 17.11.3 RECENT DEVELOPMENT 221
- 17.12 RESMED 222
- 17.12.1 COMPANY SNAPSHOT 222
- 17.12.2 REVENUE ANALYSIS 222
- 17.12.3 PRODUCT PORTFOLIO 223
- 17.12.4 RECENT DEVELOPMENTS 224
- 17.13 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 225
- 17.13.1 COMPANY SNAPSHOT 225
- 17.13.2 PRODUCT PORTFOLIO 225
- 17.13.3 RECENT DEVELOPMENT 227
- 17.14 SMITHS GROUP PLC 228
- 17.14.1 COMPANY SNAPSHOT 228
- 17.14.2 REVENUE ANALYSIS 228
- 17.14.3 PRODUCT PORTFOLIO 229
- 17.14.4 RECENT DEVELOPMENT 230
- 17.15 ZOLL MEDICAL CORPORATION 231
- 17.15.1 COMPANY SNAPSHOT 231
- 17.15.2 PRODUCT PORTFOLIO 231
- 17.15.3 RECENT DEVELOPMENT 232
18 QUESTIONNAIRE 233
19 RELATED REPORTS 236